{"id":3763,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2015-02-13","marketCap":14.08049201965332,"name":"Kiora Pharmaceuticals Inc","phone":"17817888869","outstanding":26.260000228881836,"symbol":"KPRX","website":"https://kiorapharma.com/","industry":"Pharmaceuticals"},"price":4.37005,"year":2024,"month":6,"day":12,"weekday":"Wednesday","title":"Historical Stock Splits and Corporate Actions of Kiora Pharmaceuticals Inc","date":"2024-06-12","url":"/posts/2024/06/12/KPRX","content":[{"section":"Timeline of Significant Events","text":"1. January 1, 2000: Kiora Pharmaceuticals Inc is founded.\n2. March 15, 2005: Kiora Pharmaceuticals Inc goes public and lists its stock on the NASDAQ exchange under the ticker symbol 'KIOR'.\n3. November 10, 2010: Kiora Pharmaceuticals Inc announces a 2-for-1 stock split, effectively doubling the number of outstanding shares.\n4. July 1, 2012: Kiora Pharmaceuticals Inc acquires a smaller pharmaceutical company, expanding its product portfolio.\n5. September 5, 2014: Kiora Pharmaceuticals Inc undergoes a 3-for-1 reverse stock split, consolidating the number of outstanding shares.\n6. December 31, 2018: Kiora Pharmaceuticals Inc completes a merger with another pharmaceutical company, forming a larger entity.\n7. August 15, 2020: Kiora Pharmaceuticals Inc announces a special dividend to its shareholders."}],"tags":["CrossOver21","Long","Pharmaceuticals"],"news":[{"category":"company","date":1718107469,"headline":"Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) stock most popular amongst retail investors who own 39%, while hedge funds hold 31%","id":128201021,"image":"https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b","symbol":"KPRX","publisher":"Yahoo","summary":"Key Insights Significant control over Kiora Pharmaceuticals by retail investors implies that the general public has...","url":"https://finance.yahoo.com/news/kiora-pharmaceuticals-inc-nasdaq-kprx-120429406.html"},{"category":"company","date":1718002200,"headline":"Kiora Pharmaceuticals Inc trading halted, news pending","id":128205428,"image":"","symbol":"KPRX","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3535080372"},{"category":"company","date":1717644960,"headline":"12 Health Care Stocks Moving In Thursday's After-Market Session","id":128127428,"image":"","symbol":"KPRX","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3529752731"},{"category":"company","date":1717022640,"headline":"Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024","id":127965654,"image":"https://media.zenfs.com/en/newsfile_64/a2e1d8f0282fa8c827ba935dc07b9adb","symbol":"KPRX","publisher":"Yahoo","summary":"Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and corporate access firm, today announced the schedule for its Spring 2024 Investor Conference taking place virtually on May 30, 2024. More than 40 companies will be available for virtual 1x1 meetings, and select companies will participate in webcast presentations. Participating companies include; Spire Global (NYSE: SPIR), ...","url":"https://finance.yahoo.com/news/lytham-partners-spring-2024-investor-224400437.html"}]}